Machine Learning Enables Enhanced Diagnosis of Sepsis
Researchers have developed a new diagnostic method that applies machine learning to advanced genomics data to identify and predict sepsis.
Category: Sepsis
Sepsis
Latest
Sepsis
Latest
Advances Are Needed for Newborn Sepsis Screening
In screening for sepsis in newborns, there is a need to develop sensitive, and integrated diagnostic strategies to enhance detection.
Sepsis
Latest
Turning the Tide on Hospital-Acquired Sepsis with AI
Device manufacturers that unravel technical and regulatory issues will lead the fight.
Speeding Diagnosis in Sepsis Care
Rapid molecular diagnostics contribute to improved patient outcomes.
Read MoreBeckman Coulter Receives BARDA Funding to Develop Early Sepsis Detection Algorithm
Beckman Coulter and Dascena will collaborate to develop and commercialize a novel machine-learning-based algorithm for the detection of sepsis.
Read More
Rapid IVD Aims to Alleviate Global Antimicrobial Resistance Crisis
Gradientech’s QuickMIC is a precision tool for ultrarapid antibiotic susceptibility testing.
Read More
UK Trial to Evaluate POC Test for Early Detection of Sepsis
To detect emergent sepsis, the study aims to develop a rapid diagnostic based on multiple biomarkers.
Read MoreNGS Diagnostic Platform Granted CE Certification
Disqver uses next-generation sequencing of cell-free DNA to detect more than 1,500 bacteria, DNA viruses, fungi, and parasites in a patient’s bloodstream.
Read More
FDA Clears Early Sepsis Indicator from Beckman Coulter
Beckman’s Early Sepsis Indicator is a first-of-its-kind, hematology-based cellular biomarker for identifying patients with sepsis, or those at increased risk of developing sepsis.
Read More
Quality Control Media Help to Reduce Sepsis among Patients Requiring Platelet Transfusion
BD’s quality control media for platelet testing have been CE marked and cleared by FDA.
Read More
World Sepsis Day Raises Awareness of Deadly and Often Misdiagnosed Condition
The World Health Organization has declared sepsis a global health priority; 80% of sepsis deaths in hospitals could be prevented with rapid diagnosis and treatment.
Read More
Genetic Testing Prevents Antibiotic-Related Hearing Loss in Newborns Treated for Sepsis
A bedside test identifies infants with a genetic mutation of the mitochondrial DNA responsible for irreversible hearing loss as an adverse reaction to the antibiotic gentamicin.
Read More
Beckman Coulter Files FDA 510(k) Submission for Early Sepsis Indicator
Offered as part of a routine CBC with differential test, the hematology-based solution alerts emergency department clinicians to the possibility of sepsis earlier than any other indicator.
Read More
FDA Clears T2Bacteria Panel for the Detection of Sepsis-Causing Pathogens
The first FDA-cleared test to identify sepsis-causing bacteria from whole blood decreases time to diagnosis.
Read More
Beckman Coulter Sponsors Sepsis Clinical Guide App
Beckman Coulter has exclusively sponsored the Escavo Sepsis Clinical Guide, a mobile, point-of-care medical reference application for healthcare professionals who manage septic patients in acute-care settings.
Read More
Baton Rouge General to Combat Sepsis with Wolters Kluwer Clinical Intelligence Platform
The POC Advisor will be a central component of the hospital’s overall clinical and technology strategy.
Read More
Early Treatment of Sepsis Focus of Intensive Care Conference
Diagnosis and early treatment of sepsis was one of the focus areas for this year’s congress of the European Society of Intensive Care Medicine.
Read More
Integrated Decision Support Platform Tackles Sepsis
Wolters Kluwer will integrate its POC Advisor real-time clinical surveillance and analytics platform with the Natural Language Processing solution from Hiteks Solutions for inclusion of structured and unstructured documentation to make them immediately actionable.
Read More